Expert Review of Pharmacoeconomics & Outcomes Research, Volume 24, Issue 4 (2024)

Browse this journal

Expert Review of Pharmacoeconomics & Outcomes Research, Volume 24, Issue 4 (2024)

See all volumes and issues
Volume 24, 2024 Vol 23, 2023 Vol 22, 2022 Vol 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Editorial

Editorial
A proposal of actions for stakeholders and policy makers to address the global burden of headache disorders by 2030: why is this important for global health?
Alberto Raggi, Matilde Leonardi & Paolo Martelletti
Pages: 459-461
Published online: 23 Feb 2024
First Page PreviewforA proposal of actions for stakeholders and policy makers to address the global burden of headache disorders by 2030: why is this important for global health? | Full Text | References | PDF (158.1 KB) | EPUB
  • 385 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Editorial
Using real world evidence to optimize care: the case of medical cannabis
Anne Katrin Schlag, David J Nutt & Michael Lynskey
Pages: 463-465
Published online: 23 Feb 2024
First Page PreviewforUsing real world evidence to optimize care: the case of medical cannabis | Full Text | References | PDF (137.9 KB) | EPUB
  • 605 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Special Report

Report
Using natural language processing to analyze unstructured patient-reported outcomes data derived from electronic health records for cancer populations: a systematic review
Jin-Ah Sim, Xiaolei Huang, Madeline R. Horan, Justin N. Baker & I-Chan Huang
Pages: 467-475
Published online: 05 Mar 2024
AbstractforUsing natural language processing to analyze unstructured patient-reported outcomes data derived from electronic health records for cancer populations: a systematic review | Full Text | References | PDF (1.8 MB) | EPUB | Supplemental
  • 68 Views
  • 0 CrossRef citations
  • 0Altmetric

Perspective

Comment
Drug pricing and transparency in Europe and the United States: what is it and how does it work?
Steven Simoens & Mondher Toumi
Pages: 477-486
Published online: 01 Feb 2024
AbstractforDrug pricing and transparency in Europe and the United States: what is it and how does it work? | Full Text | References | PDF (311.3 KB) | EPUB
  • 75 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

Review Article
Evaluation instruments for executive functions in children and adolescents: an update of a systematic review
Arianna Cesari, Giovanni Galeoto, Francescaroberta Panuccio, Rachele Simeon & Anna Berardi
Pages: 487-508
Published online: 06 Feb 2024
AbstractforEvaluation instruments for executive functions in children and adolescents: an update of a systematic review | Full Text | References | PDF (448.3 KB) | EPUB
  • 101 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Research

Article
Leveraging the holistic benefits of biosimilars in Europe – part 2: how payers can safeguard the future of a healthy biosimilar market environment
Jorge Mestre-Ferrandiz, Marcin Czech, Josef S. Smolen, Paul Cornes, Matti S. Aapro, Silvio Danese, Stephen Deitch, Hannah Tyldsley, Will Foster, Pooja Shah, Mark Latymer & Arnold G. Vulto
Pages: 509-519
Published online: 12 Feb 2024
AbstractforLeveraging the holistic benefits of biosimilars in Europe – part 2: how payers can safeguard the future of a healthy biosimilar market environment | Full Text | References | PDF (344.1 KB) | EPUB | Supplemental
  • 637 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Work absenteeism, disability, and lost wages among patients with acute myeloid leukemia and their caregivers: a cohort study using US administrative claims and productivity data
Bhavik J. Pandya, Christopher Young, Elizabeth R. Packnett, Bin Xie, Timothy Lillehaugen, Alana Block, Katarzyna Bernacki, Maelys Touya & Thomas W. LeBlanc
Pages: 521-532
Published online: 26 Feb 2024
AbstractforWork absenteeism, disability, and lost wages among patients with acute myeloid leukemia and their caregivers: a cohort study using US administrative claims and productivity data | Full Text | References | PDF (1.9 MB) | EPUB | Supplemental
  • 363 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Economic evaluation of clinical pharmacy service using integrated health system in tertiary care hospital
Muhammad Amir, Ale Zehra, Rabya Munawar, Wajiha Gul, Tehreem Fatima, Younas Khan, Razia Jaffery & Zaheer-Ud-Din Babar
Pages: 533-539
Published online: 20 Feb 2024
AbstractforEconomic evaluation of clinical pharmacy service using integrated health system in tertiary care hospital | Full Text | References | PDF (1.4 MB) | EPUB
  • 63 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Cost-effectiveness and drug wastage of bevacizumab biosimilar with or without chemotherapy for platinum-resistant recurrent ovarian cancer
Shih Ping Lai, Shyh-Yau Wang, Agnes LF Chan, John Hang Leung & Hei-Tung Yip
Pages: 541-549
Published online: 28 Feb 2024
AbstractforCost-effectiveness and drug wastage of bevacizumab biosimilar with or without chemotherapy for platinum-resistant recurrent ovarian cancer | Full Text | References | PDF (2.2 MB) | EPUB | Supplemental
  • 68 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS II) statement: a validated Dutch translation
Amber Werbrouck, Esther de Bekker-Grob, Maiwenn Al, Koen Putman & Ruben Willems
Pages: 551-557
Published online: 29 Feb 2024
AbstractforConsolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS II) statement: a validated Dutch translation | Full Text | References | PDF (748.4 KB) | EPUB | Supplemental
  • 42 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Cost-effectiveness comparison of dalpiciclib and abemaciclib combined with an aromatase inhibitor as first-line treatment for HR+/HER2− advanced breast cancer
Juan Hong, Tujia Chen, Lihui Ouyang, Ning Du, Anna Li, Zhongqi Zhou, HaiLing Zhang, Zhengzheng Xia & Jun Meng
Pages: 559-566
Published online: 20 Mar 2024
AbstractforCost-effectiveness comparison of dalpiciclib and abemaciclib combined with an aromatase inhibitor as first-line treatment for HR+/HER2− advanced breast cancer | Full Text | References | PDF (1.8 MB) | EPUB | Supplemental
  • 151 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
The clinical and economic burden of illness in the first two years after ostomy creation: a nationwide Danish cohort study
Frederikke Bruun Andersen, Jakob Kjellberg, Rikke Ibsen, Catarina Sternhufvud & Birte Petersen
Pages: 567-575
Published online: 07 Mar 2024
AbstractforThe clinical and economic burden of illness in the first two years after ostomy creation: a nationwide Danish cohort study | Full Text | References | PDF (682.7 KB) | EPUB | Supplemental
  • 347 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Explore articles

Explore the most recently published articles

Informing evidence-based medicine for opioid use disorder using pharmacoeconomic studies
Ali Jalali
Review Article | Published online: 9 May 2024
A retrospective budget impact analysis of fidaxomicin treatment for Clostridioides difficile infections (CDI) in Germany
Ann-Cathrine Siefen et al.
Article | Published online: 9 May 2024
A cost analysis of a simplified model for HCV screening and treatment at a tertiary hospital in Zimbabwe
Blessing Dzingirai et al.
Article | Published online: 8 May 2024
Open Access
Cost effectiveness of hepatitis C direct acting agents
Akshay Shetty et al.
Review Article | Published online: 3 May 2024
View all latest articles